The old adage that says two heads are better than one certainly seems true for Mitchell Ho, Ph.D., a senior investigator in the Center for Cancer Research, and Xiaolin Wu, Ph.D., a principal scientist in the Genomics Technology Laboratory, a CCR Core at the Frederick National Laboratory. Together, these two scientists are using next-generation genomics technology to develop, in an animal model, a chimeric antigen receptor (CAR)-T cell therapy that might help patients with hepatocellular carcinoma (HCC), the most common type of liver cancer.

A broadly based team from Frederick National Laboratory (FNL), NCI’s Technology Transfer Center, and NCI’s Office of Scientific Operations has been recognized with a 2020 NCI Director’s Award. The award, from the “Making an Impact” category, recognizes the team’s work to establish the annual Technology Showcase, an event that fosters scientific collaboration as well as licensing of NCI technologies.

The fourth annual Technology Showcase is making a big pivot this year, moving to an entirely virtual event on September 9, 2020. Although the move was made out of necessity, it also offers exciting new opportunities to reach more partners and licensees beyond Frederick, Md.